Learning Objectives:

  1. Review the biology and classification of DLBCL 
  2. Highlight the current treatment paradigm in DLBCL and areas of need
  3. Discuss a phase I/II clinical trial of lenalidomide and EPOCH-R in MYC-associated DLBCL


Session date: 
10/24/2022 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kirk Cahill, MD